fda compounded glp 1 Ends GLP-1s: What to Know FDA Ban on Compounded GLP-1

Ploy Pitayanon, MD, licensed by the Medical Council of Thailand At a Glance Peptide AOD-9604 Category Injectable Peptide Dosage 300-350mcg per injection Frequency Once daily Administration Subcutaneous injection Potential Benefits Promotes targeted fat loss Enhances fat metabolism Supports body composition improvement Quality Matters Why we use Clinical-Grade only Certificate of Analysis Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced

[T]he ingredients in these fakes are unknown and pose significant health hazards, he said

Frequency: Split this in 2-3 daily injections, 100mcg each

It also tends to stabilize over time